A Scientific and Practical Guide to the Administration and Monitoring of FcRn Blockers for Generalized Myasthenia Gravis in the Infusion Center

Myasthenia Gravis Podcast

Credit(s)

1.25

AMA PRA Category 1 CreditsTM

CPE Contact Hours

CNE Contact Hours

Pre-Test

Complete the pre-quiz poll to access the course episodes. 

Prequiz Podcast A Scientific and Practical Guide to the Administration and Monitoring of FcRn Blockers for Generalized Myasthenia Gravis in the Infusion Center

Additional Course Information

It is the policy of AcademicCME that all faculty, instructors, and planners disclose relevant financial relationships relating to the topics of this educational activity. Any relevant financial relationships are mitigated via a content review by planning committee members and faculty with no relevant financial relationships.

 

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CE activity:

 

Faculty Relationship Identified With:
James F. Howard Jr., MD Consultant/Advisor: Alexion Pharmaceuticals; Amgen; argenx; Avilar Therapeutics; Biohaven Ltd.; F. Hoffman LaRoche; Merck EMD Serono; NMD Pharma; Novartis Pharmaceuticals; Regeneron Pharma; Sanofi; Seismic Therapeutics; Toleranzia AB; UCB Bioscience

Research/Grant Support: Ad Scientiam; Alexion Pharmaceuticals; argenx; Cartesian Therapeutics; NMD Pharma; UCB Bioscience

Lauren Pica, APRN Nothing to disclose
Kipp Tiger, PharmD, CSP Nothing to disclose

 

Timothy Hayes, MD, PhD; Charles V. Pollack Jr., MD; Kim Cheramie, MSN, RN-BC; Patrick Hayes and Nicole McMenamin hereby state that they do not have any relevant financial relationships to products or devices with any commercial interests related to the content of this activity.

In support of improving patient care, AcademicCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AcademicCME designates this enduring material for a maximum of 1.25 AMA PRA Category 1 CreditsTM.

AcademicCME designates this enduring material for a maximum of 1.25 CNE Contact Hours.

AcademicCME designates this continuing education activity for 1.25 CPE Contact Hours (0.125 CEUs) of continuing pharmacy education credit (UAN #JA4008190-0000-24-010-H01-P.)

This activity has been supported by an independent educational grant.

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. AcademicCME does not recommend the use of any agent outside of the labeled indications.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

In order to claim credit, participants must complete the following:

  1. Read the accreditation information and faculty disclosures at the beginning of this activity.
  2. Read or Review the activity content.
  3. Complete the Post-Activity Test Questions and Evaluation.
  4. Learners should claim only the credit commensurate with the extent of their participation in the activity.

For all CE inquiries or special needs, please contact admin@academiccme.com.

ACCREDITATION

Earn your Credits After Completing Podcast Episodes

Related Podcast Courses

np microphone 888718 0E193A 1
Neurology
The Role of Complement Pathway Inhibitors in the Management of Chronic Inflammatory Demyel...
np microphone 888718 0E193A 1
Neurology
AANEM 2025: Conference Review and Analysis for New Data on Emerging BAFF/APRIL Inhibitors ...
np microphone 888718 0E193A 1
Neurology
Review of McDonald Criteria 2024 Updates for the Management of Patients with Multiple Scle...